Avanos Medical (AVNS) Updates FY 2018 Earnings Guidance

Avanos Medical (NYSE:AVNS) issued an update on its FY 2018 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.75-1.90 for the period.

NYSE:AVNS traded up $0.95 during trading hours on Thursday, reaching $50.61. 448,700 shares of the company were exchanged, compared to its average volume of 374,823. The company has a market capitalization of $2.31 billion, a P/E ratio of 21.52 and a beta of 1.86. Avanos Medical has a 1-year low of $43.78 and a 1-year high of $72.96. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.78 and a quick ratio of 2.18.

Avanos Medical (NYSE:AVNS) last issued its quarterly earnings results on Tuesday, November 6th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.28 by $0.09. The business had revenue of $165.10 million for the quarter, compared to the consensus estimate of $166.57 million. Avanos Medical had a return on equity of 6.59% and a net margin of 14.26%. The business’s quarterly revenue was up 9.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Avanos Medical will post 1.87 EPS for the current fiscal year.

A number of equities research analysts have weighed in on the company. Zacks Investment Research raised Avanos Medical from a hold rating to a buy rating and set a $71.00 target price on the stock in a report on Thursday, August 9th. Morgan Stanley raised their target price on Avanos Medical from $58.00 to $60.00 and gave the company an underweight rating in a report on Wednesday, August 8th. Raymond James raised Avanos Medical from a market perform rating to an outperform rating in a report on Tuesday, August 21st. KeyCorp raised their target price on Avanos Medical from $66.00 to $75.00 and gave the company an overweight rating in a report on Wednesday, August 8th. Finally, Barclays assumed coverage on Avanos Medical in a report on Monday, October 15th. They issued an equal weight rating and a $69.00 target price on the stock. Two analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the company. Avanos Medical presently has a consensus rating of Hold and a consensus price target of $69.25.

COPYRIGHT VIOLATION NOTICE: “Avanos Medical (AVNS) Updates FY 2018 Earnings Guidance” was first posted by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.wkrb13.com/2018/11/09/avanos-medical-avns-updates-fy-2018-earnings-guidance.html.

About Avanos Medical

Avanos Medical, Inc operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management.

Featured Story: Benefits of owning preferred stock

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply